About this trial
The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.
Eligibility criteria
Qualifiers
Right-handed
Monolingual (English)
Single left-hemisphere CVA
A minimum of six months post-stroke
Disqualifiers
Diagnosis of laryngeal voice disorder
Dysarthria
History of speech impairment prior to CVA
Presence of potential tDCS risk factors: damaged skin at site of stimulation;
Trial design
Treatments tested in this trial
- Soterix 1x1 line tDCS low-intensity stimulator
- Sham
Treatment groups
Sponsors and collaborators
NYU Langone Health
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator